Look up anything

Look up anything

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

back to top

Eli Lilly (LLY) Q3 2024 Earnings: Key financials and quarterly highlights | AlphaStreet

Related Article

Eli Lilly and Firm (NYSE: LLY) reported its third quarter 2024 earnings outcomes right now.

Worldwide income was $11.44 billion, up 20% in comparison with the identical interval a yr in the past.

GAAP web revenue was $970.3 million, or $1.07 per share, in comparison with a web lack of $57.4 million, or $0.06 per share, final yr. Adjusted EPS was $1.18.

Income and earnings missed expectations, sending the inventory plunging over 13% on Wednesday.  

For fiscal yr 2024, the corporate expects revenues of $45.4-46.0 billion, GAAP EPS of $12.05-12.55 and adjusted EPS of $13.02-13.52.

Prior efficiency

Eli Lilly Q2 2024 earnings infographic

Related Article